ChakrabartiSBrechlingKMossB: 1985, Vaccinia virus expression vector: Coexpressioti of B-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol5:3403–3409.
3.
HillHTCrandellRAKanitzCL: 1977, Recommended minimum standards for diagnostic tests employed in the diagnosis of pseudorabies (Aujesky's disease). Proc Annu Meet Am Assoc Vet Lab Diagn20:375–390.
4.
JavierRTSedartiFStevensJG: 1986, Two avirulent herpes simplex viruses generate lethal recombinants in vivo. Science234:746–748.
5.
KitSKitMPirtleEC: 1985, Attenuated properties of thymidine kinase negative deletion mutants of pseudorabies virus. Am J Vet Res46:1359–1367.
6.
LomnicziBWatanabeSBen-PoratTKaplanA: 1984, Genetic basis of the neurovirulence of pseudorabies virus. J Virol52: 198–205.
7.
MockRECrandellRAMesfinGM: 1981, Induced latency in pseudorabies vaccinated pigs. Can J Comp Med45:56–59.
8.
PaulPSMengelingWPirtleEC: 1982, Differentiation of pseudorabies virus strains by restriction endonuclease analysis. Arch Virol73:193–198.
9.
QuintWGielkensAVan OrischotJ: 1987, Construction and characterization of mutants of psuedorabies virus: A new generation of live vaccines. J Gen Virol68:523–534.
10.
ThawleyDGSolarzanoRFJohnsonME: 1984, Confirmation of pseudorabies virus infection using virus recrudescence by dexamethasone treatment and in vitro lymphocyte stimulation. Am J Vet Res45:981–983.
11.
ThomsenDMarchioliCYancyRPostLE: 1987, Replication and virulence of pseudorabies virus mutants lacking glycoprotein gX. J Virol61:229–232.
12.
VannVRAthertonSS: 1988, Intertypic recombinant generated after mixed intraocular infection with HSV-1 and HSV-2. Proc 13th Intl Herpes Conf, University of Calif (Davis), p. 348.